Literature DB >> 6123238

Cholinergic-like effects of the new histamine H2-receptor antagonist ranitidine.

G Bertaccini, G Coruzzi.   

Abstract

The new H2-receptor blocker ranitidine, together with the effect on histamine H2-receptors, possesses a series of cholinergic-like actions: it provokes atropine-sensitive contractions of several isolated smooth muscle preparations from different animal species and it potentiates the stimulant effect of acetylcholine. Moreover it contracts human lower esophageal sphincter in vivo, an effect which is completely prevented by small doses of atropine. Finally, ranitidine potentiates the stimulant effect of bethanechol and of carbachol on salivary glands of the rat while leaving unaffected the secretagogue effect of physalaemin which is known to be completely independent of the cholinergic system. In the in vivo experiments the doses of ranitidine capable of eliciting cholinergic-like effects were of the same order of magnitude as those necessary to cause the H2-receptor blockade.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123238     DOI: 10.1007/bf01965134

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  8 in total

1.  Effect of some vasoactive peptides on the lower esophageal sphincter.

Authors:  G Coruzzi; G Bertaccini
Journal:  Pharmacol Res Commun       Date:  1980-11

2.  Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings].

Authors:  J Bradshaw; R T Brittain; J W Clitherow; M J Daly; D Jack; B J Price; R Stables
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

3.  The effect of physalaemin and related polypeptides on salivary secretion.

Authors:  G Bertaccini; G De Caro
Journal:  J Physiol       Date:  1965-11       Impact factor: 5.182

4.  Different effects of cimetidine and ranitidine on gastric emptying in rats and man.

Authors:  C Scarpignato; G Bertaccini
Journal:  Agents Actions       Date:  1982-04

5.  [Effect of H2 histamine receptor blocking agents on the isolated lower esophageal sphincter (LES) of the rat].

Authors:  G Bertaccini; G Coruzzi
Journal:  Farmaco Sci       Date:  1981-02

6.  Effect of some new Histamine H2-receptor antagonists on the guinea-pig papillary muscle.

Authors:  G Bertaccini; G Coruzzi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

7.  Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.

Authors:  M J Daly; J M Humphray; R Stables
Journal:  Br J Pharmacol       Date:  1981-01       Impact factor: 8.739

8.  Intra-abdominal pressure and manometric data of the distal esophageal sphincter. Their relationship to gastroesophageal reflux.

Authors:  J A Wernly; T R DeMeester; G H Bryant; C I Wang; R B Smith; D B Skinner
Journal:  Arch Surg       Date:  1980-04
  8 in total
  21 in total

1.  Effects of famotidine on upper gastrointestinal motility in patients with progressive systemic sclerosis.

Authors:  T Horikoshi; T Sekiguchi; M Kusano; T Matsuzaki
Journal:  Gastroenterol Jpn       Date:  1991-04

2.  A comparison of the cholinergic activity of selected H2-antagonists and sulfoxide metabolites.

Authors:  J W Kosh; J W Sowell; J M Chapman
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

3.  H2-blocker modulates heart rate variability.

Authors:  T Ooie; T Saikawa; M Hara; H Ono; M Seike; T Sakata
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

4.  Cardiac effects of the new H2-receptor antagonists.

Authors:  G Coruzzi; E Poli; G Bertaccini
Journal:  Agents Actions       Date:  1983-04

5.  Effect of some new H2-receptor antagonists on gastrointestinal motility.

Authors:  G Bertaccini; E Poli; M Adami; G Coruzzi
Journal:  Agents Actions       Date:  1983-04

6.  Gastric acid inhibits antral phase III activity in duodenal ulcer patients.

Authors:  M Kusano; T Sekiguchi; T Nishioka; O Kawamura; K Kikuchi; T Matsuzaki; T Horikoshi
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

Review 7.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

8.  Action of the new H2-antagonist, DA 4577, on different in vitro and in vivo preparations.

Authors:  G Bertaccini; E Poli; G Coruzzi
Journal:  Agents Actions       Date:  1984-04

9.  Histamine receptors in the lower esophageal sphincter (LES).

Authors:  G Coruzzi; G Bertaccini
Journal:  Agents Actions       Date:  1982-04

10.  First-degree atrioventricular block in a young duodenal ulcer patient treated with a standard oral dose of ranitidine.

Authors:  G Allegri; K Pellegrini; G Dobrilla
Journal:  Agents Actions       Date:  1988-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.